Jubilant Pharmova Spokane CMO facility classified as VAI by US FDA
Jubilant Pharmova said the US FDA classified its Spokane, Washington CMO facility as “Voluntary Action Indicated” (VAI).
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Jubilant Pharmova said the US FDA classified its Spokane, Washington CMO facility as “Voluntary Action Indicated” (VAI).